Long-term Outcome Following Concomitant Surgical Ablation for Atrial Fibrillation at University Hospital Basel: A Retrospective Study

University Hospital, Basel, Switzerland1 site in 1 country123 target enrollmentFebruary 26, 2018

ConditionsAtrial Fibrillation Maze Procedure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Atrial Fibrillation
Sponsor: University Hospital, Basel, Switzerland
Enrollment: 123
Locations: 1
Primary Endpoint: Freedom from AF one year after surgical ablation
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This retrospective single-centre study aims to examine the success rate of concomitant surgical ablation in patients with atrial fibrillation (AF) with an up to eight years follow-up period. Moreover, the focus of this study was to identify variables which predict freedom from AF, such as the type of AF, lesion set performed, energy source used and the patient's characteristics.

Registry

clinicaltrials.gov

Start Date

February 26, 2018

End Date

October 10, 2019

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University Hospital, Basel, Switzerland

Responsible Party

Principal Investigator

Elodie Hersperger

Principal Investigator

University Hospital, Basel, Switzerland

Eligibility Criteria

Inclusion Criteria

•concomitant surgical ablation for atrial fibrillation
•performed between January 2011 and January 2017 at University Hospital Basel

Exclusion Criteria

•stand-alone procedure
•surgical ablation for atrial flutter

Outcomes

Primary Outcomes

Freedom from AF one year after surgical ablation

Time Frame: 12 months

one-year success

Secondary Outcomes

Evolution of left atrial size(from surgical ablation until 10th October 2019)
Need of additional arrhythmia interventions(from surgical ablation until 10th October 2019)
Mortality(from surgical ablation until 10th October 2019)
Freedom from atrial fibrillation (AF) and atrial flutter (AFL) after removal from antiarrhythmic drug therapy(from surgical ablation until 10th October 2019)
Perioperative morbidity(from surgical ablation until 10th October 2019)
Use of oral anticoagulation(from surgical ablation until 10th October 2019)